Moreover, in human colon cancer, estrogen receptor (ER) signaling is documented as an inhibitor of the Wnt pathway [57], which has long been implicated in initiation and progression of colorectal cancer [58], however, the mechanism by which estrogen modulates Wnt signaling is currently unknown. Here, ESR1 is linked to malignant colon neoplasm.